Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
9,219
Price
$21.37
Total Value
$197,008.19
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | May 6, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 7, 2026 |
| Shares Sold | 9,219 |
| Price per Share | $21.37 |
| Total Value | $197,008.19 |
| Shares Owned After | 9,323 |
| Derivative | No |
| Accession Number | 0001810417-26-000010 |
| Document | View SEC Filing |